99

Breakthroughs
Sub Categories on Breakthroughs
Latest Articles
Penicillin allergy? Maybe not

Penicillin allergy? Maybe not

by Deb Balzer, Mayo Clinic News NetworkChemical structure of Penicillin G. The sulfur and nitrogen of the five-membered thiazolidine ring are shown in yellow and blue respectively. The image shows tha

Penicillin allergy? Maybe not

by Deb Balzer, Mayo Clinic News NetworkChemical structure of Penicillin G. The sulfur and nitrogen of the five-membered thiazolidine ring are shown in yellow and blue respectively. The image shows tha
FDA asked to consider party drug MDMA as treatment for PTSD

FDA asked to consider party drug MDMA as treatment for PTSD

by Robin FosterA California company has asked the U.S. Food and Drug Administration to approve MDMA, the active ingredient in party drugs like molly and ecstasy, as a treatment for post-traumatic stre

FDA asked to consider party drug MDMA as treatment for PTSD

by Robin FosterA California company has asked the U.S. Food and Drug Administration to approve MDMA, the active ingredient in party drugs like molly and ecstasy, as a treatment for post-traumatic stre
COVID-19 viral load rebound can occur after VV116, nirmatrelvir-ritonavir

COVID-19 viral load rebound can occur after VV116, nirmatrelvir-ritonavir

by Elana GotkineFor patients with mild-to-moderate COVID-19, viral load rebound and symptom rebound can occur after a standard five-day course of treatment with VV116 or nirmatrelvir-ritonavir, accord

COVID-19 viral load rebound can occur after VV116, nirmatrelvir-ritonavir

by Elana GotkineFor patients with mild-to-moderate COVID-19, viral load rebound and symptom rebound can occur after a standard five-day course of treatment with VV116 or nirmatrelvir-ritonavir, accord
Study finds AI can develop treatments to prevent 'superbugs'

Study finds AI can develop treatments to prevent 'superbugs'

byCleveland ClinicSchematic evolutionary simulation and tested optimization approaches. Credit:Proceedings of the National Academy of Sciences(2024). DOI: 10.1073/pnas.2303165121Clev

Study finds AI can develop treatments to prevent 'superbugs'

byCleveland ClinicSchematic evolutionary simulation and tested optimization approaches. Credit:Proceedings of the National Academy of Sciences(2024). DOI: 10.1073/pnas.2303165121Clev
Scientists discover a framework in the brain for organizing the order of things

Scientists discover a framework in the brain for organizing the order of things

byNorwegian University of Science and TechnologyUltraslow oscillations in MEC neurons.a, Neural activity was recorded through a prism from GCaMP6m-expressing neurons of the MEC in head-fix

Scientists discover a framework in the brain for organizing the order of things

byNorwegian University of Science and TechnologyUltraslow oscillations in MEC neurons.a, Neural activity was recorded through a prism from GCaMP6m-expressing neurons of the MEC in head-fix
Follow-up finds landmark steroid study remains safe 50 years on

Follow-up finds landmark steroid study remains safe 50 years on

byUniversity of AucklandCredit: Bruno Abdiel from PexelsA study has found there are no adverse long-term cardiovascular health consequences for the now-adult children of mothers who were given c

Follow-up finds landmark steroid study remains safe 50 years on

byUniversity of AucklandCredit: Bruno Abdiel from PexelsA study has found there are no adverse long-term cardiovascular health consequences for the now-adult children of mothers who were given c
Autophagy-tethering compounds may open new directions in targeted drug discovery

Autophagy-tethering compounds may open new directions in targeted drug discovery

byScience China Press(A) Molecular glue ATTECs are targeting polyQ proteins in neurodegenerative disorders. (B) Bifunctional ATTECs targeting oncoprotein BRD4. (C) Bifunctional ATTECs targeting

Autophagy-tethering compounds may open new directions in targeted drug discovery

byScience China Press(A) Molecular glue ATTECs are targeting polyQ proteins in neurodegenerative disorders. (B) Bifunctional ATTECs targeting oncoprotein BRD4. (C) Bifunctional ATTECs targeting
Popular blood thinner associated with higher risk of bleeding complications

Popular blood thinner associated with higher risk of bleeding complications

byUniversity of MichiganCredit: Pixabay/CC0 Public DomainWhen diagnosed with a blood clot or atrial fibrillation, patients are often prescribed anticoagulants, or blood thinners, to prevent a fu

Popular blood thinner associated with higher risk of bleeding complications

byUniversity of MichiganCredit: Pixabay/CC0 Public DomainWhen diagnosed with a blood clot or atrial fibrillation, patients are often prescribed anticoagulants, or blood thinners, to prevent a fu
New technique reveals earliest signs of genetic mutations

New technique reveals earliest signs of genetic mutations

by NYU Langone HealthCredit: Unsplash/CC0 Public DomainMutations are changes in the molecular "letters" that make up the DNA code, the blueprint for all living cells. Some of these chan

New technique reveals earliest signs of genetic mutations

by NYU Langone HealthCredit: Unsplash/CC0 Public DomainMutations are changes in the molecular "letters" that make up the DNA code, the blueprint for all living cells. Some of these chan
New combination therapy found effective against drug-sensitive and resistant tick-borne babesiosis

New combination therapy found effective against drug-sensitive and resistant tick-borne babesiosis

by Isabella Backman,Yale UniversityThe lab of Choukri Ben Mamoun, PhD (left), has a long-standing interest in fighting this tick-borne disease. Credit: Yale UniversityDrug-resistant babesiosis m

New combination therapy found effective against drug-sensitive and resistant tick-borne babesiosis

by Isabella Backman,Yale UniversityThe lab of Choukri Ben Mamoun, PhD (left), has a long-standing interest in fighting this tick-borne disease. Credit: Yale UniversityDrug-resistant babesiosis m
Novel compound AC102 restores hearing in preclinical models of sudden hearing loss

Novel compound AC102 restores hearing in preclinical models of sudden hearing loss

by AudioCure Pharma GmbHThe effect of AC102 on OHC survival after noise exposure in vivo. (A) Schematic of OHCs and IHCs within the cochlea. (B) Quantification of OHCs 14 d after noise exposure reveal

Novel compound AC102 restores hearing in preclinical models of sudden hearing loss

by AudioCure Pharma GmbHThe effect of AC102 on OHC survival after noise exposure in vivo. (A) Schematic of OHCs and IHCs within the cochlea. (B) Quantification of OHCs 14 d after noise exposure reveal